Clinical Trials
246 trialsPACHA-02
UNICANCER
TRIBE-C
Sun Yat-sen University
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
Alliance for Clinical Trials in Oncology
GRECCAR 5
University Hospital, Bordeaux
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study
Alliance for Clinical Trials in Oncology
PANEX3
University Hospital, Caen
COLOCROSS
Centre Oscar Lambret
ALASCCA
Karolinska Institutet
00-046
Memorial Sloan Kettering Cancer Center
Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer
City of Hope Medical Center
ASPIK French
University Hospital, Rouen
Combination With Sintilimab and XELOX+Bevacizumab as 1st Line Therapy in RAS-mutant Metastatic Colorectal Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
INCISIVE
University Hospital, Rouen
CAPRI-3 GOIM
University of Campania Luigi Vanvitelli
IRIMAD
Assistance Publique - Hôpitaux de Paris
Fruquintinib Versus Bevacizumab Plus Chemotherapy in Second-Line RAS-Mutant Metastatic Colorectal Cancer (FRU-RAS)
Fudan University
ALTAIR
National Cancer Center Hospital East
CIRCULATEIII
UNICANCER
Neuroprotective Effect of Neurotropin on Chronic OXA-induced Neurotoxicity in Stage II and Stage III CRC Patients
Sun Yat-sen University
NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Cancer
Shanghai Zhongshan Hospital
BASKETâ…¢
Sixth Affiliated Hospital, Sun Yat-sen University
AIO-KRK-0418
Charite University, Berlin, Germany
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
University of Pittsburgh
Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial
City of Hope Medical Center
AtezoTRIBE2
Gruppo Oncologico del Nord-Ovest
FOXHIPECT4
Maimónides Biomedical Research Institute of Córdoba
NEXT-REGIRI
Institut du Cancer de Montpellier - Val d'Aurelle
RIFIONA
Centre Hospitalier Universitaire, Amiens
The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients
Tanta University
ColoRectal Cancer Screening for Southern California Community Health Centers
University of California, San Diego
PROTINCOL
Galician Research Group on Digestive Tumors
PROPAC
University Hospital, Geneva
COLAGE
GERCOR - Multidisciplinary Oncology Cooperative Group
OSCAR
Federation Francophone de Cancerologie Digestive
Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours
University College, London
FIRE-11
Charite University, Berlin, Germany
EFFIPEC
Uppsala University
REGTAS-2
Second Affiliated Hospital, School of Medicine, Zhejiang University
SPARKLE-L
Sixth Affiliated Hospital, Sun Yat-sen University
AIO-KRK-0114
Ludwig-Maximilians - University of Munich
ENSEMBLE
National Cancer Center Hospital East
PUMP-IT RCT
The Netherlands Cancer Institute
CAIRO5
Dutch Colorectal Cancer Group
ITACa
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer
Alliance for Clinical Trials in Oncology
Conversion Therapy of RAS/BRAF Wild-Type Colorectal Cancer Patients With Initially Unresectable Liver Metastases
Fudan University
SMALLER
Sun Yat-sen University
Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer
Fudan University
CR-SEQUENCE
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
RISIS-CR
National University Hospital, Singapore